Biora Therapeutics has reached an agreement with certain of its prepetition creditors to provide financing to support a chapter 11 sale process. The company has filed a voluntary petition under chapter 11 of the U.S. Bankruptcy Code in the District of Delaware.
The Lenders have agreed to provide the company with a debtor in possession financing facility of up to $10.25 million. This funding is expected to allow Biora to meet its obligations arising during the chapter 11 case to vendors, suppliers, employees and other stakeholders as it pursues a court-supervised sale process.
Biora intends to file a motion requesting approval of a marketing and sale process. The Bid Procedures Motion will facilitate a competitive bidding process under section 363 of the Bankruptcy Code. The Lenders have agreed to serve as a stalking horse bidder for the companys assets.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.